Bacil Pharma Ltd is in Pharmaceutical businessOperational Status: Company is non operational for the past many years. It has not carried out any major business activity and management is considering diversifying their business activities and have deployed surplus funds as temporary loans and advances
Bacil Pharma Limited has announced that its statutory auditor, M/s Laxmikant Kabra & Co LLP, has resigned. The auditor was appointed in September 2022 and was scheduled to serve until the 35th Annual General Meeting in 2027. They had submitted audit reports for the year ended March 2025 and a...
Here are the summaries based on the provided document: **Bacil Pharma Limited** Bacil Pharma Limited has submitted the newspaper clippings of its unaudited financial results for the quarter ended June 30, 2025, to the stock exchange. This update signifies that the company's latest financial performance has been published, making key...
Reg Office: G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai – 400099 Email Id: bacilpha@yahoo.com, CIN: L24200MH1987PLC043427, Tel: 22618452/22661541, Tel/Fax: 22618327 To, The Manager – Listing Department BSE Limited P. J. Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 524516 Scrip ID: BACPHAR Subject:...
Bacil Pharma Limited announces that Prakash Bhoorchand Shah has resigned as a Director of the company, with immediate effect. Mr. Shah cited 'pre-occupation' as the reason for his departure from the board. This development signals a change in the company's leadership composition. For investors, changes in directorship are significant as...
BACIL Pharma has submitted a certificate from Bigshare Services, its Registrar and Transfer Agent, for the latest quarter. This confirms the company's compliance with regulations concerning share dematerialization. All securities received for electronic conversion were processed correctly, listed on stock exchanges, and physical certificates were cancelled. The depository's name was...
